Tumor molecular pathology is an evolving field dedicated to uncovering the molecular underpinnings of cancer development and progression. This discipline ...
CDK4/6 inhibitors like abemaciclib and ribociclib improve invasive disease-free survival in breast cancer trials, but controversy surrounds study designs, bias, and cost-effectiveness, raising ...